Atrium Therapeutics
RNA11.9753.77% ( +0.435 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Atrium Therapeutics(RNA) predict that the Revenue is 19.64 M (--%), Beat estimate;the EBIT is -17.28 M (--%), Beat estimate;the EPS is -0.97 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.02B--
0.00B--
+0.02B--%
EBITExceed expectations
-0.02B--
-0.02B--
+0.00B--%
EPSExceed expectations
-0.97--
-1.05--
+0.0800--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf